Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of VZV-7D varicella vaccine in children aged 1–12 years
ChiCTR2500104433Phase 3Not yet recruiting
- Sponsor
- Shandong Center for Disease Control and Prevention
- Start
- Jun 2025
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chickenpox comparing Experimental group (VZV-7D) with Placebo group (2 arms). Primary endpoint: Laboratory-confirmed varicella cases 42 days after vaccination. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
vzv-7d
03
Conditions
chickenpox
Beyond the preview
Go deeper on ChiCTR2500104433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104433.